A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
<h4>Introduction</h4>Diabetes remains a growing public health concern in Egypt, as prevalence of Type II diabetes (TIID) has nearly tripled there in the last two decades. Egypt was ranked ninth worldwide in number of diabetes cases, with prevalence of 15.56% among adults. Recent studies...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238764 |
id |
doaj-dbc21199978a44ee93cdd6748686691a |
---|---|
record_format |
Article |
spelling |
doaj-dbc21199978a44ee93cdd6748686691a2021-03-04T11:13:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01159e023876410.1371/journal.pone.0238764A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.Sahar RadwanDarby GilfillanBridget EklundHend M RadwanNagwan G El MenofyJustin LeeMarylee KapuscinskiZaid Abdo<h4>Introduction</h4>Diabetes remains a growing public health concern in Egypt, as prevalence of Type II diabetes (TIID) has nearly tripled there in the last two decades. Egypt was ranked ninth worldwide in number of diabetes cases, with prevalence of 15.56% among adults. Recent studies have proposed that disturbance of gut microbiota could influence TIID development and indicated associations between a reduced diversity in microbiomes and Type I diabetes (TID). In the present study, we investigated the composition and abundance of the bacterial microbiome in disease state (TID and TIID) of Egyptian patients. Our goal in this study was to characterize features of the gut microbiota and possible differences associated with TID and TIID in this population.<h4>Methods</h4>DNA was extracted from fecal samples taken from 22 TID and 18 TIID outpatients of Al-Hussein hospital, Cairo, Egypt. 16S rRNA amplicon sequencing was used to characterize the bacterial taxa and these reads were processed using the software mothur with analysis utilizing packages vegan, phyloseq and metagenomSeq in R.<h4>Results and conclusions</h4>Our results highlighted a significant increase in abundance of Gram negative, potentially opportunistic pathogenic taxa (Pseudomonas, Prevotella) in all diabetic groups, compared to the control. Lipopolysccharide (LPS), a component of the gram-negative bacterial wall, can activate local immune response and may result in low-grade systemic inflammation contributing to insulin resistance. The gram-positive Gemella, which is associated with increased risk to diabetes, also had a significant increase in abundance in all diabetic groups, compared to the control. In contrast, the commensal bacterial taxa Turicibacter, Terrisporobacter and Clostridium were found to be more abundant in the control group than in TID. Further studies are needed to understand the role of these taxa in health and disease. Lower Richness and low Shannon diversity, though not statistically significant, were observed for TID subjects with no glucose control and with onset of liver disease or hypertension compared to other subjects. In addition, large variation in alpha diversity within the control group could also be observed. Future studies will include larger samples sizes to further elucidate these findings, as well as possible metagenomic studies to examine the intriguing function of significant microbes.https://doi.org/10.1371/journal.pone.0238764 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sahar Radwan Darby Gilfillan Bridget Eklund Hend M Radwan Nagwan G El Menofy Justin Lee Marylee Kapuscinski Zaid Abdo |
spellingShingle |
Sahar Radwan Darby Gilfillan Bridget Eklund Hend M Radwan Nagwan G El Menofy Justin Lee Marylee Kapuscinski Zaid Abdo A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. PLoS ONE |
author_facet |
Sahar Radwan Darby Gilfillan Bridget Eklund Hend M Radwan Nagwan G El Menofy Justin Lee Marylee Kapuscinski Zaid Abdo |
author_sort |
Sahar Radwan |
title |
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. |
title_short |
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. |
title_full |
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. |
title_fullStr |
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. |
title_full_unstemmed |
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. |
title_sort |
comparative study of the gut microbiome in egyptian patients with type i and type ii diabetes. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
<h4>Introduction</h4>Diabetes remains a growing public health concern in Egypt, as prevalence of Type II diabetes (TIID) has nearly tripled there in the last two decades. Egypt was ranked ninth worldwide in number of diabetes cases, with prevalence of 15.56% among adults. Recent studies have proposed that disturbance of gut microbiota could influence TIID development and indicated associations between a reduced diversity in microbiomes and Type I diabetes (TID). In the present study, we investigated the composition and abundance of the bacterial microbiome in disease state (TID and TIID) of Egyptian patients. Our goal in this study was to characterize features of the gut microbiota and possible differences associated with TID and TIID in this population.<h4>Methods</h4>DNA was extracted from fecal samples taken from 22 TID and 18 TIID outpatients of Al-Hussein hospital, Cairo, Egypt. 16S rRNA amplicon sequencing was used to characterize the bacterial taxa and these reads were processed using the software mothur with analysis utilizing packages vegan, phyloseq and metagenomSeq in R.<h4>Results and conclusions</h4>Our results highlighted a significant increase in abundance of Gram negative, potentially opportunistic pathogenic taxa (Pseudomonas, Prevotella) in all diabetic groups, compared to the control. Lipopolysccharide (LPS), a component of the gram-negative bacterial wall, can activate local immune response and may result in low-grade systemic inflammation contributing to insulin resistance. The gram-positive Gemella, which is associated with increased risk to diabetes, also had a significant increase in abundance in all diabetic groups, compared to the control. In contrast, the commensal bacterial taxa Turicibacter, Terrisporobacter and Clostridium were found to be more abundant in the control group than in TID. Further studies are needed to understand the role of these taxa in health and disease. Lower Richness and low Shannon diversity, though not statistically significant, were observed for TID subjects with no glucose control and with onset of liver disease or hypertension compared to other subjects. In addition, large variation in alpha diversity within the control group could also be observed. Future studies will include larger samples sizes to further elucidate these findings, as well as possible metagenomic studies to examine the intriguing function of significant microbes. |
url |
https://doi.org/10.1371/journal.pone.0238764 |
work_keys_str_mv |
AT saharradwan acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT darbygilfillan acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT bridgeteklund acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT hendmradwan acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT nagwangelmenofy acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT justinlee acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT maryleekapuscinski acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT zaidabdo acomparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT saharradwan comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT darbygilfillan comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT bridgeteklund comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT hendmradwan comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT nagwangelmenofy comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT justinlee comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT maryleekapuscinski comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes AT zaidabdo comparativestudyofthegutmicrobiomeinegyptianpatientswithtypeiandtypeiidiabetes |
_version_ |
1714804451346219008 |